Tuesday, December 7th, 2021

There is no scientific evidence to support the necessity for a booster vaccine dose against Covid-19.

According to reports, the booster dose issue would most likely be addressed at the next meeting of India’s National Technical Advisory Group on Immunization (NTAGI). 

There is no scientific evidence to justify the need for a booster vaccine dose against COVID-19, said ICMR Director-General, Dr. Balram Bhargava, on Monday, emphasizing that the completion of the second dose for India’s adult population is the government’s priority for the time being. 

According to reports, the booster dose issue would most likely be addressed at the next meeting of India’s National Technical Advisory Group on Immunization (NTAGI). 

The main priority to administer 2nd dose first 

“For the time being, the government’s priority is to administer the second dosage of COVID-19 vaccine to all adult population and ensure that not only India but the entire world, is vaccinated.” 

“More importantly, there is no scientific evidence to justify the necessity for a booster vaccine dose against COVID-19 at this time,” Bhargava told PTI. Union Health Minister Mansukh Mandaviya recently stated that adequate stocks are available and that the goal is to complete the immunization of the target population with two doses. Following that, a decision on a booster dose will be made based on professional advice, he had stated. 

“In such a case, the government cannot make a direct judgment.” “We will examine it when the Indian Council of Medical Development and expert team agree that a booster dose should be given,” he had stated, adding that Prime Minister Narendra Modi has always relied on expert opinion, whether in vaccine research, production, or approval. 

According to officials, approximately 82% of the eligible population in India has got the first dosage of the vaccine, while approximately 43% has been fully immunized. 

According to preliminary reports as of 7 a.m., the total number of COVID-19 vaccine doses provided in the country has surpassed 116.87 crores. 

The government has initiated a month-long ‘Har Ghar Dastak’ campaign to provide house-to-house COVID-19 vaccination to individuals who have yet to receive a dose and those whose second dosage is past due. 

According to reports, the booster dose issue would most likely be addressed at the next meeting of India’s National Technical Advisory Group on Immunization (NTAGI).¬†

Connect with Us

Leave a Reply

Your email address will not be published. Required fields are marked *